Labcorp to Buy Myriad Genetics Prenatal Testing Business for $210 Million
Myriad Genetics agreed to sell its prenatal health testing business to Labcorp for $210 million in cash plus the value of inventory. The business includes Prequel, Foresight, SneakPeek and FirstGene.
Myriad Genetics has agreed to sell its prenatal health testing business to Labcorp for $210 million in cash, plus the value of inventory. The companies said Tuesday they signed a definitive agreement covering the business, which includes Prequel, Foresight, SneakPeek and FirstGene.